FDA Inspection
Appco Pharma LLCAppco Pharma LLC – FDA Inspection, Aug 29, 2023
Record Details
This FDA Inspection record concerns Appco Pharma LLC, with an inspection on August 29, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 773429a4-2a26-471f-8bf2-77c3a2f2fdef
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1216223
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.142Written warehousing procedures established/followed
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.46(b)Equipment for Environmental Control
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Appco Pharma LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 14, 2026 | Not classified | New Jersey District Office | Drug Quality Assurance |
| March 11, 2024 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| August 19, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 28, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Appco Pharma LLC
- FDA Inspection 1301504 - 2026-05-14
- FDA Inspection 1232512 - 2024-03-11
- FDA Inspection 1179037 - 2022-08-19
- FDA Inspection 1122406 - 2020-03-27
- FDA Inspection 1093238 - 2019-05-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.